PURCHASE, NY, July 23, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC) ("Teladoc") today announced a proposed sale of shares of its common stock, which includes 5,000,000 shares offered by Teladoc and 263,740 shares received in connection with Teladoc's recent acquisition of Advance Medical-HealthCare Management Services, S.A. ("Advance Medical") and offered by certain entities affiliated with Summit Partners and certain former employees of Advance Medical (the "selling stockholders"). The underwriter has a 30-day option to purchase up to an additional 750,000 shares of common stock from the selling stockholders. The last reported sale price of Teladoc's common stock on July 23, 2018, was $69.57 per share. The offering is expected to close and settle on or about July 26, 2018, subject to customary closing conditions.